PCL (241820.KQ) Stock Price

PCL Price

CLOSED
6,425.53
​
Market closed

Over the last 11 years PCL grew revenue by 7.3% annually, reaching 1.25 B KRW. For PCL, the net margin of -4,200.0% is down versus 36.3% a few years ago.

PCL stock price

Access this data via the Eulerpool API

PCL business model & stock analysis

PCL, Inc. engages in the manufacturing of medical devices. The company is headquartered in Seoul, Seoul. The company went IPO on 2017-02-23. The Company’s products include blood bank screening products and quick diagnostic products. And the Company also provides platform services.

Frequently asked questions about PCL

Converted at the current exchange rate, the PCL share trades at 4.18 EUR (6,425.53 KRW).

The revenue cannot currently be calculated for PCL.

The profit cannot currently be calculated for PCL.

The P/E ratio cannot be calculated for PCL at the moment.

The P/S cannot be calculated for PCL currently.

The Eulerpool Quality Score for PCL is 1/10.

The ISIN of PCL is KR7241820000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PCL is 241820.KQ. The ticker symbol is used to trade PCL shares on the stock exchange.

Fair ValueTerminal
6,811.06 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
17.31 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website pclchip.com
Country
South Korea
Currency
KRW
Initial public offering
Feb 23, 2017
ISIN
KR7241820000
Cusip
Y6S79Y101
Market capitalization
360.80 B KRWMega Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
50.70
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-289.09 %
Gross Margin
-827.34 %
EBIT Margin
—
Net Margin
-4,199.97 %
EPS (Earnings Per Share)
-884.52 KRW
Net Debt / EBIT
—
Debt/Equity
1.54
Last updated Oct 2, 2026, 2:01 AM

PCL Peer Group

PCL FIGI

241820:KS · BBG00FD8LWZ2241820:KQ · BBG00FD8LX17

All fundamentals and in-depth analysis of PCL

Our stock analysis for PCL stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PCL. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.